Search
Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma
Lessons in Herding Cats – Business Development Basics for Life Science Companies
Time: 11:30AMLocation: LobbyRegister LabCentral…
Massachusetts biotechs behind one-in-six drugs approved by FDA this year
Arsia Therapeutics Inc. and Biogen Sign a Research Collaboration for the Development of Subcutaneous Biologics
Cambridge startup teams up with Biogen on hemophilia drugs
Art Reception and Teen Media Program Mid-Semester Showcase
Time: 5:30PM - 7:30PMLocation: LobbyLearn about…